Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL25019

FCF.N

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2339 0.89
SCHEMBL23044067 0.89
SCHEMBL27688441 0.80
SCHEMBL6113934 0.80
Hydrochloric Acid SCHEMBL27474265 0.80
Water SCHEMBL25365379 0.80
Bromide SCHEMBL27827082 0.80
SCHEMBL11038950 0.80
Hydrochloric Acid SCHEMBL9799153 0.80
Hydrogen Sulfide SCHEMBL28222002 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109867645-A A kind of synthetic method of 2,2- bis- fluoro- 2,3- dihydro substitution benzofuran compounds 中国医学科学院药物研究所 2019-06-11 CN claimed
US-8623883-B2 4-phenylamino-quinazolin-6-yl-amides WARNER-LAMBERT COMPANY LLC (US) 2014-01-07 US disclosed
US-20130274275-A1 4-PHENYLAMINO-QUINAZOLIN-6-YL-AMIDES WARNER-LAMBERT COMPANY LLC 2013-10-17 US disclosed
US-8466165-B2 4-phenylamino-quinazolin-6-yl-amides WARNER-LAMBERT COMPANY LLC (US) 2013-06-18 US disclosed
EP-1746999-B1 4-PHENYLAMINO-QUINAZOLIN-6-YL-AMIDES WARNER LAMBERT CO (US) 2011-11-16 EP disclosed
US-20110262877-A1 HEAT TREATMENT APPARATUS IHI CORPORATION (JP) 2011-10-27 US disclosed
US-7772243-B2 4-phenylamino-quinazolin-6-yl-amides WARNER-LAMBERT COMPANY LLC (US) 2010-08-10 US disclosed
US-20100190977-A1 4-PHENYLAMINO-QUINAZOLIN-6-YL-AMIDES PFIZER INC. 2010-07-29 US disclosed
US-7307185-B2 Process for producing optically active fluorochemical MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2007-12-11 US disclosed
US-20050250761-A1 such as -Piperidin-1-yl-but-2-enoic acid [4(3-chloro-4-fluoro-phenylamino)-7-methoxy-quinazolin-6-yl]-amide, used as tyrosine kinase inhibitors, for the prevention of proliferative diseases, including cancer, atherosclerosis, restenosis, endometriosis and psoriasis PFIZER INC 2005-11-10 US disclosed
CN-1140167-A Process for preparing substituted 2-amino tetrahydronaphthalenes and 3-aminochromanes LILLY CO ELI (US) 1997-01-15 CN disclosed
EP-0007600-B1 ALPHA-DIFLUOROMETHYL AMINO ACIDS AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME MERCK & CO. INC. (US) 1983-05-11 EP disclosed
EP-0007600-A1 Alpha-difluoromethyl amino acids and pharmaceutical composition containing the same MERCK & CO. INC. (US) 1980-02-06 EP disclosed